Research Article

Effects of CoQ10 Replacement Therapy on the Audiological Characteristics of Pediatric Patients with COQ6 Variants

Table 1

Phenotypes and genotypes of 12 patients with biallelic COQ6 variants.

Patients/gender1/M2/F3/F4/F5/F6/M7/M8-1/M8-2/F9/M10/M11/F

Genotypes
COQ6K64del/P261LK64del/Q229PK64del/P261LK64del/P261LK64del/P261LK64del/P261LQ229P/P261LK64del/P261LK64del/P261LQ229P/P261LR162/P261LP261L, homozygote
COQ8B c.521A>GA/GA/GA/GA/AA/AA/GA/GA/AA/GG/GNot doneNot done
Kidney phenotypes
Age of onset (y)3.92.03.92.71.23.10.81.13.01.19.16.9
Mode of onsetSRNSSRNSSRNSSRNSSRNSSRNSSRNSSRNSSRNSSRNSSRNSPU
Kidney biopsyFSGS, collFSGSFSGS, collFSGS, collFSGSFSGSFSGSFSGS, cellNot doneFSGSFSGSFSGS
Kidney function at start of CoQ10 TxESKDESKDESKDESKDESKDESKDAKI St 2CKD G3NormalCKD G1AKI St 3 on CKD G2CKD G1
Kidney outcome at the last follow-upESKDESKDESKDESKDESKDESKDESKDESKDCKD G1CKD G1CKD G3CKD G2
Age at ESKD (y)6.23.14.04.61.43.51.51.3
Age at KT (y)11.56.56.37.26.44.92.72.6
Periods from onset to CoQ10 Tx (y)9.82.87.15.613.712.90.10.23.90.96.6
Audiological phenotypes
Age at SNHL (y)6.02.54.46.31.55.91.21.35.05.23.6
Age at initial audiometry (y)12.46.04.32.91.65.90.91.25.05.44.213.9
Initial hearing level (R/L) (dB)120/12084/8055/6035/35NR/NR60/6025/2585/6059/6062/6255/507/4
Initial hearing level (R/L) (degree)ProfoundSevereModerate/mod-severeMildProfoundMod-severeMildSevere/mod-severeMod-severeMod-severeModerateNormal
Threshold difference between two ears (dB)0450000251053
Symmetry+++++++++++
Rehabilitation status at initial audiometry(R) CI, (L) HA(B) HANoneNone(B) HANoneNoneNoneNoneNoneNoneNone
Other phenotypesMm weak, nystagmusExotropia, nystagmus, bilat OANoneNoneBilat OADCMP, Mm weakNoneAtlantoaxial dislocationNoneNoneNoneNone